Etao International Shares Resume Trading
Save time and jump to the most important pieces.
NEW YORK, Dec. 21, 2023 /PRNewswire/ -- The board of directors (the "Board") of ETAO International Co. Ltd. (the "Company") approved the appointment of Ryoshin Nakade, as ETAO Japan president of the Company, effective on November 22, 2023. Wensheng (Wilson) Liu, Chairman and CEO of ETAO stated, "We are thrilled about ETAO's new appointment of Ryoshin Nakade as ETAO Japan president. With the support of Mr. Ryoshin Nakade, ETAO would scale up its 'Buy Build and Expand' and 'Online Merging Offline 'strategy in Asian market quickly. We hope that in turn would speed up the development and market penetration of ETAO's integrated healthcare services for global customers." ETAO Announces Appointmen
Gainers CytomX Therapeutics (NASDAQ:CTMX) stock increased by 87.1% to $7.84 during Wednesday's after-market session. The market value of their outstanding shares is at $534.1 million. As per the press release, Q1 earnings came out today. ZimVie (NASDAQ:ZIMV) shares increased by 17.03% to $18.0. The company's market cap stands at $489.9 million. The company's, Q1 earnings came out today. Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 15.0% to $0.53. The market value of their outstanding shares is at $25.2 million. electroCore (NASDAQ:ECOR) shares rose 11.98% to $7.85. The market value of their outstanding shares is at $47.1 million. The company's, Q1 earnings came out today.
Gainers INVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release, Q4 earnings came out yesterday. Clene (NASDAQ:CLNN) shares moved upwards by 40.8% to $0.44. The market value of their outstanding shares is at $56.0 million. Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 31.76% to $0.22. The market value of their outstanding shares is at $12.1 million. Vanda Pharma (NASDAQ:VNDA) stock moved upwards by 26.91% to $5.14. The company's market cap stands at $295.7 million. Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 23.62% to $2.25
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million. Jaguar Health (NASDAQ:JAGX) shares rose 32.22% to $0.12. The market value of their outstanding shares is at $32.8 million. Orgenesis (NASDAQ:ORGS) stock rose 27.83% to $0.62. The market value of their outstanding shares is at $21.1 million. BioSig Technologies (NASDAQ:BSGM) shares moved upwards by 15.43% to $1.87. The company's market cap stands at $17.4 million. Etao International Co (NASDAQ:ETAO) shares rose 14.65% to $4.38. The company's market cap stands at $22.4 million. Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 12.84%
20-F/A - ETAO International Co., Ltd. (0001939696) (Filer)
6-K - ETAO International Co., Ltd. (0001939696) (Filer)
NT 20-F - ETAO International Co., Ltd. (0001939696) (Filer)
This press release has been corrected to include further details regarding the reverse stock split of ETAO International Co., Ltd. We hereby issue a formal amendment to supersede our previously released press release dated March 19, 2024. This amended communication is intended to replace the original statement in its entirety and provides updated, accurate information. We advise all stakeholders to refer to this latest version for the most current details regarding the matter previously addressed. NEW YORK, March 21, 2024 /PRNewswire/ -- ETAO International Co., Ltd. (the "Company," "we" or "ETAO") (NASDAQ:ETAO), today announced that a 1 for 20 reverse split of its ordinary shares, an increas
NEW YORK, Jan. 12, 2024 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination – Delinquency letter (the "Letter"), on January 5, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company has not yet filed its interim financial statements for the period ended June 30, 2023 (the "Filing"), it no longer complies with our Listing Rules (the "Rules") for continued listing. Accordingly, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. Under Nasdaq rules, a Company that receives a delist determination for delinquency, can request an appea
NEW YORK, Dec. 21, 2023 /PRNewswire/ -- The board of directors (the "Board") of ETAO International Co. Ltd. (the "Company") approved the appointment of Ryoshin Nakade, as ETAO Japan president of the Company, effective on November 22, 2023. Wensheng (Wilson) Liu, Chairman and CEO of ETAO stated, "We are thrilled about ETAO's new appointment of Ryoshin Nakade as ETAO Japan president. With the support of Mr. Ryoshin Nakade, ETAO would scale up its 'Buy Build and Expand' and 'Online Merging Offline 'strategy in Asian market quickly. We hope that in turn would speed up the development and market penetration of ETAO's integrated healthcare services for global customers." ETAO Announces Appointmen